SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors anticipate critical clinical trial results and a potential acquisition, fueling a technical short squeeze driven by record short interest. The community is actively discussing the stock's parabolic move and the strategic implications of recent corporate filings ahead of imminent trial data readouts.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix Inc. is trending as investors digest a strong earnings report and raised full-year guidance, with community discussion focused on the potential for institutional accumulation and the ongoing commercial buildout for the company's broader anti-infective platform. While some shareholders are debating the long-term growth outlook and patient adoption metrics, many are actively monitoring the stock's ability to maintain upward momentum as they look for catalysts beyond the DefenCath franchise.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc is currently attracting significant community attention following its latest quarterly earnings report, which highlighted record profitability and the launch of a $75 million share buyback program. While bulls are energized by these financial improvements and new strategic partnerships, the broader conversation remains divided as skeptics point to stalled policy growth and a history of volatility, leaving investors closely watching whether these new initiatives can sustain long-term momentum.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is facing intense selling pressure as investors react to concerns over the pace of YARTEMLEA commercial adoption and the recent departure of key executive leadership. Despite this, the community remains divided, with many long-term shareholders actively accumulating shares at lower prices, viewing the drop as a manipulation-driven opportunity ahead of imminent J-Code reimbursement, European regulatory milestones, and potential milestones from the Novo Nordisk partnership.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing high volatility as investors react to a new strategic agreement with Fit Energy for up to 380 MW of clean power, fueling debates over potential future dilution versus the company's long-term commercial execution in the AI data center space. The community is actively discussing the company's scaling efforts and comparing its trajectory to peers, while analysts have sparked fresh interest with recent upgrades reflecting optimism for its utility-scale fuel cell technology.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is experiencing intense volatility as investors debate whether the recent surge represents a fundamental AI-driven rerate or a speculative bubble prone to a technical correction. Community discussions are heavily focused on the stock's parabolic trajectory and the potential for a sharp pullback, with many debating the optimal entry points amid concerns over market-wide valuation levels.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund is experiencing heightened volatility as investors weigh the impact of persistent supply disruptions in the Strait of Hormuz against ongoing, yet inconclusive, diplomatic negotiations between the U.S. and Iran. The community remains deeply divided, with many traders closely monitoring inventory depletion rates and shipping traffic as key indicators of whether the sector is facing a structural energy supply crisis or a temporary geopolitical premium.

TOYO Co. Ltd. engages in the design, manufacture, and sale of solar cells and modules. It is involved in integrating the upstream production of wafer and silicon, midstream production of solar cell, downstream production of photovoltaic (PV) modules, and potentially other stages of the solar power supply chain. The company was founded on November 8, 2022 and is headquartered in Tokyo, Japan.

TOYO Co Ltd.

TOYO Co., Ltd

TOYO is seeing increased investor scrutiny as market participants debate the potential impact of an anti-circumvention probe and the stock's recent capital raise. While some community members express concern over the company's wafer supply chain and potential retroactive tariffs, others remain bullish on TOYO's domestic manufacturing ramp-up in Texas and its fundamental valuation.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

United Airlines is experiencing significant momentum as investors digest resilient summer travel demand projections alongside ongoing sector-wide volatility linked to fluctuating fuel costs. The community is closely monitoring how the carrier will manage margin pressures and capacity adjustments while navigating complex macroeconomic signals and geopolitical developments impacting the broader aviation industry.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is trending due to its emerging role in AI data center power infrastructure, with investors reacting positively to its new solid-state transformer technology and recent insider buying by the CEO. Community sentiment remains polarized, with bullish discussions focusing on a potential short squeeze and long-term data center opportunities, while bears continue to highlight concerns regarding residential solar market headwinds and rapid price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Could Buying VTI Today Set You Up for Life?

Key PointsThe Vanguard Total Stock Market ETF (VTI) holds many of the same top companies as the S&P 500 but also includes small- and mid-cap stocks...

VRDN Stock Jumps 6% After-Hours As Viridian Wins First FDA Approval  

Equity

The FDA approved Viridian’s Lumvoa for the treatment of thyroid eye disease. 


S&P 500, Nasdaq End Week Lower As Investors Rotate Out Of Tech, AI Plays — ON, AAPL, SLS, INFQ, NKE in Focus

The Dow Jones ended its third consecutive week higher amid cooling oil prices and strength in pharma and materials stocks. 

ARDX Stock Tumbles As Xphozah Loses Final Medicare Reimbursement Battle  

The U.S. Court of Appeals for the D.C. Circuit said federal law prevents judges from reviewing Medicare’s decision to include certain kidney drugs in the dialysis payment bundle.


UNCY Stock On Track For Worst Day In About A Year Ahead Of FDA Decision On Lead Drug 

Unicyive Therapeutics is awaiting word on whether its main drug, oxylanthanum carbonate, will be approved to treat hyperphosphatemia in patients with chronic kidney disease on dialysis following a previous rejection.


IBRX Stock Surges 12% On Russell 1000 Inclusion Hopes 

The semi-annual reconstitution of the index, based on market capitalizations as of April 30, 2026, will take effect after the U.S. market close on Friday, June 26. 

AAPL Stock On-Track For Worst Week In Four Months — Mac, iPad Price Hikes Spurs Demand, Margins Debate 

Morgan Stanley thinks Apple’s big price hike is seen as "an unprecedented push to protect margins."

ACAD Stock Eyes Best Day In Over A Year As CHMP Recommends Approval For Rare Nerve Disorder Drug In Europe

The European Commission will review the recommendation and is expected to issue a final decision in the coming months.


Apple Hiked Prices Of Its Products Due To Soaring Memory Costs — And Dan Ives Says AAPL Can Get Away With It

Wedbush maintained its ‘Outperform’ rating and $400 price target, implying an upside potential of 45% from Thursday’s closing price.

KYMR Stock Clocks Best Day In Over 6 Months On Advancing Eczema Trial Timeline

Kymera said that it finished enrolling patients nearly six months ahead of schedule in a mid-stage trial for KT-621.


Vanguard Index Funds - Vanguard Total Stock Market ETF

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$362.22
Prev Close	$362.94
Open	$360.88
Dividend Yield	N/A
50-Day Moving Average	$361.72
Beta	N/A
Avg. Volume	3.21M
PE Ratio	N/A

52-Week High	$374.70
52-Week Low	$301.39
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

VTIVanguard Total Stock Market ETF

Latest VTI News